deoxyglucose has been researched along with Critical Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballantyne, CM; Ballew, SH; Coresh, J; Ding, N; Folsom, AR; Heiss, G; Hirsch, AT; Hoogeveen, RC; Jaar, B; Kwak, L; Matsushita, K; Salameh, M; Selvin, E; Sharrett, AR | 1 |
| Bergmans, DC; Schalkwijk, CG; van Bussel, BC; van de Poll, MC | 1 |
1 review(s) available for deoxyglucose and Critical Illness
| Article | Year |
|---|---|
Increased Dicarbonyl Stress as a Novel Mechanism of Multi-Organ Failure in Critical Illness.
Topics: Biomarkers; Comorbidity; Critical Care; Critical Illness; Deoxyglucose; Glyoxal; Humans; Hypoxia; Inflammation; Multiple Organ Failure; Pyruvaldehyde; Stress, Physiological | 2017 |
1 other study(ies) available for deoxyglucose and Critical Illness
| Article | Year |
|---|---|
Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
Topics: Biomarkers; Blood Glucose; Critical Illness; Deoxyglucose; Diabetes Mellitus; Diabetic Foot; Disease Progression; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Incidence; Ischemia; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Prevalence; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Serum Albumin; Severity of Illness Index; Time Factors; United States | 2018 |